Switching and Discontinuation Patterns Among Patients Stable on Originator Infliximab Who Switched to an Infliximab Biosimilar or Remained on Originator Infliximab

類似資料

• Effectiveness and safety of switching IBD patients from the originator to the biosimilar infliximab
  著者:: Strik, Anne S, 等
  出版事項: (2018)
• Long-term follow up after switching from original infliximab to an infliximab biosimilar: real-world data
  著者:: María Fernanda Guerra Veloz, 等
  出版事項: (2019-06-01)
• Rapid loss of efficacy of biosimilar infliximab in three patients with Behçet’s disease after switching from infliximab originator
  著者:: Cantini, Fabrizio, 等
  出版事項: (2017)
• Long-term follow up after switching from original infliximab to an infliximab biosimilar: real-world data
  著者:: Guerra Veloz, María Fernanda, 等
  出版事項: (2019)
• Loss of efficacy and safety of the switch from infliximab original to infliximab biosimilar (CT-P13) in patients with inflammatory bowel disease
  著者:: Guerra Veloz, María Fernanda, 等
  出版事項: (2018)